These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38650308)

  • 1. Change of voltage-gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model.
    Butenko O; Jensen SM; Fillié-Grijpma YE; Verpalen R; Verschuuren JJ; van der Maarel SM; Huijbers MG; Plomp JJ
    Eur J Neurosci; 2024 Jun; 59(12):3292-3308. PubMed ID: 38650308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
    Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
    Huijbers MG; Plomp JJ; van Es IE; Fillié-Grijpma YE; Kamar-Al Majidi S; Ulrichts P; de Haard H; Hofman E; van der Maarel SM; Verschuuren JJ
    Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.
    Cole RN; Ghazanfari N; Ngo ST; Gervásio OL; Reddel SW; Phillips WD
    J Physiol; 2010 Sep; 588(Pt 17):3217-29. PubMed ID: 20603331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
    Richman DP; Nishi K; Morell SW; Chang JM; Ferns MJ; Wollmann RL; Maselli RA; Schnier J; Agius MA
    Arch Neurol; 2012 Apr; 69(4):453-60. PubMed ID: 22158720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.
    Mori S; Shigemoto K
    Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure.
    Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD
    Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSK antibodies, lessons learned from poly- and monoclonality.
    Vergoossen DLE; Augustinus R; Huijbers MG
    J Autoimmun; 2020 Aug; 112():102488. PubMed ID: 32505442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
    Koneczny I; Cossins J; Vincent A
    J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
    Koneczny I; Herbst R
    Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK.
    Lim JL; Augustinus R; Plomp JJ; Roya-Kouchaki K; Vergoossen DLE; Fillié-Grijpma Y; Struijk J; Thomas R; Salvatori D; Steyaert C; Blanchetot C; Vanhauwaert R; Silence K; van der Maarel SM; Verschuuren JJ; Huijbers MG
    Sci Rep; 2023 May; 13(1):7478. PubMed ID: 37156800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
    Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
    Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.